2, 6-naphthyridine derivatives as protein kinase modulators

Details for Australian Patent Application No. 2008235455 (hide)

Owner Novartis AG

Inventors Gaul, Christoph; Van Eis, Maurice; Von Matt, Anette; Schuler, Walter; Soldermann, Nicolas; Monovich, Lauren G.

Agent Davies Collison Cave

Pub. Number AU-A-2008235455

PCT Pub. Number WO2008/122614

Priority 60/910,469 06.04.07 US

Filing date 4 April 2008

Wipo publication date 16 October 2008

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/4745 (2006.01)

Event Publications

15 October 2009 PCT application entered the National Phase

  PCT publication WO2008/122614 Priority application(s): WO2008/122614

23 August 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008235456-[2, 6] naphthyridines useful as protein kinase inhibitors

2008235440-Method and device for obtaining a volume data set of a mobile tissue or organ of a patient